BiotechTube
Home/MyoGene Bio/Dr. Melissa Spencer
DM

Dr. Melissa Spencer

Scientific Advisor, Co-founder

MyoGene Bio

Therapeutic Areas

Muscular DisordersRare Disease

MyoGene Bio Pipeline

DrugIndicationPhase
MyoDys45-55Duchenne Muscular Dystrophy (mutations in exons 45-55)Pre-clinical

Leadership Team at MyoGene Bio

DC
Dr. Courtney Young
CEO, Co-founder
DA
Dr. April Pyle
Scientific Advisor, Co-founder
View full MyoGene Bio profile